Sotera Health (SHC) Cash from Financing Activities (2020 - 2026)
Sotera Health (SHC) recorded quarterly Cash from Financing Activities of -$12.8 million in Q1 2026, down 56.32% quarter-over-quarter from -$8.2 million in Q4 2025, and down 58.02% on a YoY basis from -$30.4 million in Q1 2025.
Sotera Health (SHC) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Sotera Health's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$12.8 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 58.02% year-over-year to -$12.8 million; the TTM figure through Mar 2026 stood at -$105.2 million (down 125.28% YoY), while the FY2025 annual figure was -$100.5 million, down 98.83% from the prior year.
- Cash from Financing Activities was -$12.8 million for Q1 2026 at Sotera Health, down from -$8.2 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $273.9 million in Q1 2023 to a low of -$77.3 million in Q3 2025.
- Historically, Cash from Financing Activities has averaged $17.6 million across 5 years, with a median of -$3.8 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities soared 61105.79% in 2023, then tumbled 4043.8% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $199.2 million in 2022, then tumbled by 101.9% to -$3.8 million in 2023, then plunged by 72.63% to -$6.5 million in 2024, then declined by 24.85% to -$8.2 million in 2025, then sank by 56.32% to -$12.8 million in 2026.
- The last three Cash from Financing Activities figures came in at -$12.8 million (Q1 2026), -$8.2 million (Q4 2025), and -$77.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Sotera Health | 4.72 Bn | 4.40 Bn | 147.07 Mn | -12.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.78 Mn |
| Mar 31, 2026 | -12.78 Mn |
| Dec 31, 2025 | -8.18 Mn |
| Dec 31, 2025 | -8.18 Mn |
| Sep 30, 2025 | -77.34 Mn |
| Sep 30, 2025 | -77.34 Mn |
| Jun 30, 2025 | -6.93 Mn |
| Jun 30, 2025 | -6.93 Mn |
| Mar 31, 2025 | -8.09 Mn |
| Mar 31, 2025 | -8.09 Mn |
| Dec 31, 2024 | -6.55 Mn |
| Dec 31, 2024 | -6.55 Mn |
| Sep 30, 2024 | -2.65 Mn |
| Sep 30, 2024 | -2.65 Mn |
| Jun 30, 2024 | -29.42 Mn |
| Jun 30, 2024 | -29.42 Mn |
| Mar 31, 2024 | -11.94 Mn |
| Mar 31, 2024 | -11.94 Mn |
| Dec 31, 2023 | -3.79 Mn |
| Dec 31, 2023 | -3.79 Mn |